Luca Monzo

Pubblicazioni

Titolo Pubblicato in Anno
High risk of stroke in patients with worsening heart failure, reduced ejection fraction, coronary heart disease and sinus rhythm. risk prediction score analysis from the COMMANDER-HF trial JOURNAL OF CARDIAC FAILURE 2024
Pressure overload is associated with right ventricular dyssynchrony in heart failure with reduced ejection fraction ESC HEART FAILURE 2024
Use of the win ratio analysis in critical care trials AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2024
Tackling the ReD(S) flag of congestion in heart failure JACC. HEART FAILURE 2024
Hypothermia in patients with cardiac arrest prior to ECMO-VA: Insight from the HYPO-ECMO trial RESUSCITATION 2024
Circulating beta-hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact EUROPEAN JOURNAL OF HEART FAILURE 2024
Iron deficiency and supplementation in patients with heart failure: Results from the IRON-HF international survey EUROPEAN JOURNAL OF HEART FAILURE 2024
Decoding proteins in cardiometabolic disease: the power and challenges of proteomics HEART 2024
Association of ventricular-arterial coupling with biomarkers involved in heart failure pathophysiology - the STANISLAS cohort EUROPEAN JOURNAL OF HEART FAILURE 2024
Multimodality imaging in sarcomeric hypertrophic cardiomyopathy: get it right…on time LIFE 2023
Letter by Monzo and Melenovsky Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF" CIRCULATION 2023
Treating chronic kidney disease to reduce cardiovascular risk EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
The Different Pathways of Epicardial Adipose Tissue across the Heart Failure Phenotypes: From Pathophysiology to Therapeutic Target INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2023
Optimal management of patients after acute coronary syndrome EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
Bempedoic acid. what prospective uses EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
The implantable cardiac monitor in heart failure patient. a possible new indication EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
Sodium-glucose co-transporter 2 inhibitors in heart failure. an updated evidence-based practical guidance for clinicians EUROPEAN HEART JOURNAL SUPPLEMENTS 2023
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction. a subgroups analysis from the EMPHASIS-HF trial EUROPEAN JOURNAL OF HEART FAILURE 2023
Electrocardiographic characteristics of right-bundle-branch-block premature ventricular complexes predicting absence of left ventricular scar in athletes with apparently structural normal heart EUROPACE 2023
Role of aldosterone in mid- and long-term left ventricular remodelling after acute myocardial infarction. the REMI study EUROPEAN JOURNAL OF HEART FAILURE 2023

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma